Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Southern Illinois University School of Medicine

Southern Illinois University School of Medicine in Springfield, Illinois, United States is listed as a site for 608 registered clinical trials, 314 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 608
Ongoing 314

This page covers the site record Southern Illinois University School of Medicine in Springfield, Illinois, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Southern Illinois University School of Medicine report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 608 trials counted.

  • Phase 1 18 trials
  • Phase 1/2 19 trials
  • Phase 2 202 trials
  • Phase 2/3 44 trials
  • Phase 3 241 trials
  • Phase 4 4 trials
  • Not applicable 29 trials
  • Observational 49 trials
  • Expanded access 1 trial
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 314 trials
  • Completed 230 trials
  • Terminated 52 trials
  • Other 12 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 46

1995: 1 trials (Phase 3 1) 1996: 2 trials (Phase 3 1, Phase 2 1) 1997: 1 trials (Phase 3 1) 1998: 5 trials (Phase 3 1, Phase 2 4) 1999: 7 trials (Observational 1, Phase 3 4, Phase 2 2) 2000: 5 trials (Observational 1, Phase 4 1, Phase 3 1, Phase 2 1, Phase 1 1) 2001: 7 trials (Not applicable 1, Phase 3 4, Phase 2 2) 2002: 6 trials (Phase 4 1, Phase 3 2, Phase 2 2, Phase 1 1) 2003: 6 trials (Observational 1, Phase 3 1, Phase 2/3 2, Phase 2 2) 2004: 9 trials (Observational 3, Not applicable 1, Phase 3 1, Phase 2 4) 2005: 6 trials (Phase 3 3, Phase 2 1, Phase 1 2) 2006: 15 trials (Observational 3, Phase 3 5, Phase 2 5, Phase 1/2 1, Phase 1 1) 2007: 14 trials (Other 1, Observational 1, Not applicable 1, Phase 3 8, Phase 2 3) 2008: 11 trials (Observational 5, Not applicable 1, Phase 4 1, Phase 3 2, Phase 2/3 1, Phase 2 1) 2009: 12 trials (Observational 2, Not applicable 1, Phase 3 5, Phase 2 2, Phase 1 2) 2010: 19 trials (Observational 2, Not applicable 1, Phase 3 7, Phase 2 5, Phase 1/2 3, Phase 1 1) 2011: 20 trials (Observational 3, Not applicable 1, Phase 3 8, Phase 2/3 1, Phase 2 4, Phase 1/2 2, Phase 1 1) 2012: 20 trials (Observational 1, Not applicable 1, Phase 3 8, Phase 2/3 1, Phase 2 5, Phase 1/2 3, Phase 1 1) 2013: 22 trials (Phase 3 10, Phase 2 9, Phase 1/2 1, Phase 1 2) 2014: 38 trials (Observational 2, Not applicable 3, Phase 3 15, Phase 2/3 6, Phase 2 8, Phase 1/2 3, Phase 1 1) 2015: 32 trials (Observational 3, Not applicable 1, Phase 3 10, Phase 2/3 3, Phase 2 12, Phase 1/2 1, Phase 1 2) 2016: 17 trials (Observational 1, Phase 3 7, Phase 2 9) 2017: 32 trials (Observational 1, Not applicable 1, Phase 3 10, Phase 2/3 1, Phase 2 18, Phase 1 1) 2018: 41 trials (Observational 3, Not applicable 2, Phase 3 14, Phase 2/3 2, Phase 2 18, Phase 1/2 1, Phase 1 1) 2019: 46 trials (Observational 4, Not applicable 2, Phase 3 19, Phase 2/3 6, Phase 2 15) 2020: 40 trials (Observational 4, Phase 3 18, Phase 2/3 3, Phase 2 15) 2021: 36 trials (Observational 2, Not applicable 2, Phase 3 11, Phase 2/3 4, Phase 2 15, Phase 1/2 1, Phase 1 1) 2022: 28 trials (Observational 2, Not applicable 1, Phase 3 9, Phase 2/3 6, Phase 2 9, Phase 1/2 1) 2023: 37 trials (Observational 3, Not applicable 1, Phase 3 18, Phase 2/3 4, Phase 2 10, Phase 1/2 1) 2024: 29 trials (Not applicable 5, Phase 3 9, Phase 2/3 3, Phase 2 12) 2025: 31 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 21, Phase 2/3 1, Phase 2 5, Phase 1/2 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 9
2025 31
2024 29
2023 37
2022 28
2021 36
2020 40
2019 46
2018 41
2017 32

Showing 10 of 32 years.

Start your 14-day trial Email me all 32 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 608 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 69 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 315 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF